NO314383B1 - Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk - Google Patents

Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk Download PDF

Info

Publication number: NO314383B1
Authority: NO; Norway
Prior art keywords: pro; milk; ile; seq; gly
Prior art date: 1995-12-27

Application number

NO19982777A

Other languages

English (en)

Norwegian (no)

Other versions

NO982777D0 (no

NO982777L (no

Inventor

Paolo Pozzilli

Original Assignee

Midia Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-27

Filing date

1998-06-16

Publication date

2003-03-17

1998-06-16 Application filed by Midia Ltd filed Critical Midia Ltd

1998-06-16 Publication of NO982777D0 publication Critical patent/NO982777D0/no

1998-06-16 Publication of NO982777L publication Critical patent/NO982777L/no

2003-03-17 Publication of NO314383B1 publication Critical patent/NO314383B1/no

Links

102000011632 Caseins Human genes 0.000 title claims abstract description 85
108010076119 Caseins Proteins 0.000 title claims abstract description 85
235000021247 β-casein Nutrition 0.000 title claims abstract description 50
235000013336 milk Nutrition 0.000 title claims abstract description 42
239000008267 milk Substances 0.000 title claims abstract description 42
210000004080 milk Anatomy 0.000 title claims abstract description 42
235000005911 diet Nutrition 0.000 claims abstract description 26
230000037213 diet Effects 0.000 claims abstract description 19
230000002265 prevention Effects 0.000 claims abstract 6
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 27
235000021240 caseins Nutrition 0.000 claims description 27
206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 18
238000000034 method Methods 0.000 claims description 17
239000005018 casein Substances 0.000 claims description 15
150000001413 amino acids Chemical class 0.000 claims description 14
241001465754 Metazoa Species 0.000 claims description 13
229940021722 caseins Drugs 0.000 claims description 12
239000000825 pharmaceutical preparation Substances 0.000 claims description 12
229940127557 pharmaceutical product Drugs 0.000 claims description 12
235000018102 proteins Nutrition 0.000 claims description 11
102000004169 proteins and genes Human genes 0.000 claims description 11
108090000623 proteins and genes Proteins 0.000 claims description 11
230000002163 immunogen Effects 0.000 claims description 10
101000947120 Homo sapiens Beta-casein Proteins 0.000 claims description 9
102000058058 Glucose Transporter Type 2 Human genes 0.000 claims description 8
108091006299 SLC2A2 Proteins 0.000 claims description 8
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
230000000378 dietary effect Effects 0.000 claims description 7
239000000203 mixture Substances 0.000 claims description 7
108090000765 processed proteins & peptides Proteins 0.000 claims description 6
102000004196 processed proteins & peptides Human genes 0.000 claims description 4
230000007062 hydrolysis Effects 0.000 claims description 3
238000006460 hydrolysis reaction Methods 0.000 claims description 3
235000016709 nutrition Nutrition 0.000 claims description 3
244000005700 microbiome Species 0.000 claims description 2
238000002360 preparation method Methods 0.000 claims description 2
102000007079 Peptide Fragments Human genes 0.000 claims 2
108010033276 Peptide Fragments Proteins 0.000 claims 2
238000010353 genetic engineering Methods 0.000 claims 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 12
102000004877 Insulin Human genes 0.000 abstract description 6
108090001061 Insulin Proteins 0.000 abstract description 6
229940125396 insulin Drugs 0.000 abstract description 6
230000001419 dependent effect Effects 0.000 abstract 1
239000000047 product Substances 0.000 description 24
239000004202 carbamide Substances 0.000 description 12
239000000872 buffer Substances 0.000 description 11
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 10
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
239000001632 sodium acetate Substances 0.000 description 8
235000017281 sodium acetate Nutrition 0.000 description 8
235000013305 food Nutrition 0.000 description 7
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 6
241000283690 Bos taurus Species 0.000 description 5
239000002253 acid Substances 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
235000020247 cow milk Nutrition 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
238000004587 chromatography analysis Methods 0.000 description 3
238000010828 elution Methods 0.000 description 3
239000012634 fragment Substances 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
230000028993 immune response Effects 0.000 description 3
238000011068 loading method Methods 0.000 description 3
210000000496 pancreas Anatomy 0.000 description 3
238000011045 prefiltration Methods 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
238000000926 separation method Methods 0.000 description 3
235000013311 vegetables Nutrition 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
239000003480 eluent Substances 0.000 description 2
235000020256 human milk Nutrition 0.000 description 2
210000004251 human milk Anatomy 0.000 description 2
239000012528 membrane Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012360 testing method Methods 0.000 description 2
235000021249 α-casein Nutrition 0.000 description 2
235000021246 κ-casein Nutrition 0.000 description 2
BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000283725 Bos Species 0.000 description 1
241000283699 Bos indicus Species 0.000 description 1
101000741065 Bos taurus Beta-casein Proteins 0.000 description 1
102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108091052347 Glucose transporter family Proteins 0.000 description 1
102000014171 Milk Proteins Human genes 0.000 description 1
108010011756 Milk Proteins Proteins 0.000 description 1
241001494479 Pecora Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
238000003916 acid precipitation Methods 0.000 description 1
238000012435 analytical chromatography Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
238000013375 chromatographic separation Methods 0.000 description 1
238000010367 cloning Methods 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
238000011026 diafiltration Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
235000020251 goat milk Nutrition 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
238000009776 industrial production Methods 0.000 description 1
235000021129 infant diet Nutrition 0.000 description 1
230000010354 integration Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000000622 liquid--liquid extraction Methods 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
235000021239 milk protein Nutrition 0.000 description 1
235000015927 pasta Nutrition 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000012466 permeate Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
235000020254 sheep milk Nutrition 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
238000011282 treatment Methods 0.000 description 1
238000000108 ultra-filtration Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000003643 water by type Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/832—Milk; colostrum

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Polymers & Plastics (AREA)
Genetics & Genomics (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Emergency Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Dairy Products (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Feed For Specific Animals (AREA)
Shafts, Cranks, Connecting Bars, And Related Bearings (AREA)
Steering Controls (AREA)

NO19982777A 1995-12-27 1998-06-16 Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk NO314383B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT95RM000850A IT1277964B1 (it)	1995-12-27	1995-12-27	Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso
PCT/EP1996/005846 WO1997024371A1 (en)	1995-12-27	1996-12-27	Product derived from milk substantially free of beta casein from non-human mammals and relative use

Publications (3)

Publication Number	Publication Date
NO982777D0 NO982777D0 (no)	1998-06-16
NO982777L NO982777L (no)	1998-06-16
NO314383B1 true NO314383B1 (no)	2003-03-17

Family

ID=11403735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19982777A NO314383B1 (no)	1995-12-27	1998-06-16	Produkt avledet fra melk hovedsakelig fritt for betakasein fra ikke-humanepattedyr, relativ anvendelse og melk

Country Status (12)

Country	Link
US (2)	US6750203B1 (de)
EP (1)	EP0871662B1 (de)
AT (1)	ATE207079T1 (de)
AU (1)	AU720411B2 (de)
BR (1)	BR9612346A (de)
CA (1)	CA2241171C (de)
DE (1)	DE69616088T2 (de)
ES (1)	ES2164938T3 (de)
IT (1)	IT1277964B1 (de)
NO (1)	NO314383B1 (de)
NZ (1)	NZ325826A (de)
WO (1)	WO1997024371A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7094949B2 (en) *	1995-05-16	2006-08-22	A2 Corporation Limited	Breeding and milking cows for milk free of β-casein A1
GB9912852D0 (en) *	1999-06-02	1999-08-04	Regen Therapeutics Plc	Peptides
GB0029777D0 (en) *	2000-12-06	2001-01-17	Regen Therapeutics Plc	Peptides
EP1568707A1 (de) *	2004-02-26	2005-08-31	Puleva Biotech, S.A.	Blutdrucksenkenden Peptiden aus Kaseinhydrolysaten
EP2270133B1 (de) *	2008-04-22	2015-06-24	Corporación Alimentaria Peñasanta (Capsa)	Verfahren zur gewinnung eines neuen strangs aus bifidobacterium bifidum mit wirkung gegen infektionen durch helicobacter pylori
WO2010119088A2 (en) *	2009-04-15	2010-10-21	Bodo Melnik	Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
US9289461B2 (en)	2013-03-15	2016-03-22	Mead Johnson Nutrition Company	Reducing the risk of autoimmune disease
US9352020B2 (en)	2013-03-15	2016-05-31	Mead Johnson Nutrition Company	Reducing proinflammatory response
US9138455B2 (en)	2013-03-15	2015-09-22	Mead Johnson Nutrition Company	Activating adiponectin by casein hydrolysate
US8889633B2 (en)	2013-03-15	2014-11-18	Mead Johnson Nutrition Company	Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
EP3962289A4 (de) *	2019-05-02	2023-04-12	New Culture Inc.	Käse- und joghurtähnliche zusammensetzungen und zugehörige verfahren
US11771105B2 (en)	2021-08-17	2023-10-03	New Culture Inc.	Dairy-like compositions and related methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4501585A (en) *	1982-08-23	1985-02-26	Friedman Laura L	Mother's milk harvesting and collection device
EP0279582A3 (de) *	1987-02-17	1989-10-18	Pharming B.V.	DNA-Sequenzen die Proteine zwecks effizienter Abscheidung zur Milchdrüse leiten
JP2623342B2 (ja) *	1989-06-01	1997-06-25	雪印乳業株式会社	脱塩乳類の製造方法
FR2650955B1 (fr) *	1989-08-16	1992-01-10	Agronomique Inst Nat Rech	Procede d'obtention, a partir de la caseine beta, de fractions enrichies en peptides a activite biologique et les fractions peptidiques obtenues
US5795611A (en) *	1989-12-20	1998-08-18	Slattery; Charles W.	Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
FR2663637B1 (fr)	1990-06-25	1992-09-18	Eurial	Procede et dispositif pour l'obtention de caseine beta.
WO1993004171A1 (en) *	1991-08-19	1993-03-04	Symbicom Aktiebolag	Human beta-casein, process for producing it and use thereof
EP0661927A4 (de) *	1992-09-22	1996-01-24	New Zealand Dairy Board	Verfahren zur herstellung von produkten mit hohem beta-kaseingehalt.
FR2714390B1 (fr) *	1993-12-23	1996-03-08	Agronomique Inst Nat Rech	Procédé d'obtention de produits peptidiques et produits obtenus.
US5643880A (en) *	1994-05-26	1997-07-01	Abbott Laboratories	Product for inhibition of attachment of H. influenzae to human cells
CA2204245C (en) *	1994-11-04	2008-07-22	Robert Bartlett Elliott	Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
CA2217820C (en) *	1995-05-16	2011-03-01	Corran Norman Stuart Mclachlan	Milk and milk products for preventing or treating heart disease

1995
- 1995-12-27 IT IT95RM000850A patent/IT1277964B1/it active IP Right Grant
1996
- 1996-12-27 ES ES96944662T patent/ES2164938T3/es not_active Expired - Lifetime
- 1996-12-27 BR BR9612346-0A patent/BR9612346A/pt not_active Application Discontinuation
- 1996-12-27 CA CA002241171A patent/CA2241171C/en not_active Expired - Lifetime
- 1996-12-27 US US09/095,639 patent/US6750203B1/en not_active Expired - Lifetime
- 1996-12-27 AT AT96944662T patent/ATE207079T1/de active
- 1996-12-27 DE DE69616088T patent/DE69616088T2/de not_active Expired - Lifetime
- 1996-12-27 EP EP96944662A patent/EP0871662B1/de not_active Expired - Lifetime
- 1996-12-27 NZ NZ325826A patent/NZ325826A/xx not_active IP Right Cessation
- 1996-12-27 WO PCT/EP1996/005846 patent/WO1997024371A1/en not_active Ceased
- 1996-12-27 AU AU13066/97A patent/AU720411B2/en not_active Expired
1998
- 1998-06-16 NO NO19982777A patent/NO314383B1/no not_active IP Right Cessation
2004
- 2004-03-04 US US10/793,111 patent/US7091320B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2164938T3 (es)	2002-03-01
NZ325826A (en)	2000-05-26
BR9612346A (pt)	1999-12-28
AU1306697A (en)	1997-07-28
WO1997024371A1 (en)	1997-07-10
EP0871662A1 (de)	1998-10-21
ATE207079T1 (de)	2001-11-15
IT1277964B1 (it)	1997-11-12
DE69616088T2 (de)	2002-08-01
CA2241171C (en)	2007-11-13
ITRM950850A1 (it)	1997-06-27
US20050176638A1 (en)	2005-08-11
NO982777D0 (no)	1998-06-16
US6750203B1 (en)	2004-06-15
EP0871662B1 (de)	2001-10-17
AU720411B2 (en)	2000-06-01
DE69616088D1 (de)	2001-11-22
ITRM950850A0 (de)	1995-12-27
CA2241171A1 (en)	1997-07-10
NO982777L (no)	1998-06-16
US7091320B2 (en)	2006-08-15

Legal Events

Date	Code	Title	Description
2017-01-09	MK1K	Patent expired

Publication	Publication Date	Title
KR940003938B1 (ko)	1994-05-09	펩타이드 제제의 제조방법
TWI251468B (en)	2006-03-21	A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
Schlimme et al.	1995	Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects
Chabance et al.	1995	Characterization of an antithrombotic peptide from α-casein in newborn plasma after milk ingestion
Thomä-Worringer et al.	2006	Health effects and technological features of caseinomacropeptide
De Meulenaer et al.	2001	Isolation and purification of chicken egg yolk immunoglobulins: a review
Morgan et al.	1999	Glycation of bovine β-lactoglobulin: effect on the protein structure
US5744179A (en)	1998-04-28	Low-phosphorus whey protein, manufacturing method thereof, low-phosphorus purified whey hydrolysate and manufacturing method thereof
AU2014324897A1 (en)	2016-05-19	Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
US7091320B2 (en)	2006-08-15	Product derived from milk substantially free of beta casein from non-human mammals and relative use
AU734222B2 (en)	2001-06-07	Method for the selective degradation of milk protein in the presence of other m ilk proteins
Korhonen et al.	1998	The functional and biological properties of whey proteins: prospects for the development of functional foods
Huang et al.	1985	Investigation of the allergenicity of β-lactoglobulin and its cleavage fragments
DK0871366T3 (da)	2005-10-10	Födevareprodukt og fremgangsmåde til fremstilling heraf
EP0487619B1 (de)	1994-10-12	Von casein-beta ausgehendes verfahren zur herstellung von fraktionen, die mit biologisch aktiven peptiden angereichert sind sowie die so erhaltenen peptidfraktionen
EP3430390B1 (de)	2022-08-03	Molekularer ursprung der allergie
JP2000503531A (ja)	2000-03-28	非ヒト哺乳動物由来のベータカゼインを実質的に含まない乳から誘導された生産物及び関連する使用
US20040162244A1 (en)	2004-08-19	Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof
JP3657067B2 (ja)	2005-06-08	低タンパク・低アレルゲン米の製造方法並びに加工食品の製造方法
Tullio et al.	2007	Isolation and purification of milk whey glycomacropeptide
JPS6248358A (ja)	1987-03-03	卵白分解物の製法
JPH067092A (ja)	1994-01-18	新規タンパク食品素材
JP2003325131A (ja)	2003-11-18	アレルゲン低減天然エキスの製造法
Lee et al.	0	frorn the Root of Panar ginslsw
NO873481L (no)	1987-10-13	Peptidpreparat, fremgangsmaate for fremstilling derav og anvendelse av peptidpreparatet.